Literature DB >> 9268383

Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.

J R Graff1, J G Herman, S Myöhänen, S B Baylin, P M Vertino.   

Abstract

Promoter region CpG island methylation is associated with tumor suppressor gene silencing in neoplasia. GenBank sequence analyses revealed that a number of CpG islands are juxtaposed to multiple Alu repeats, which have been proposed as "de novo methylation centers." These islands also contain multiple Sp1 elements located upstream and downstream of transcription start, which have been shown to protect CpG islands from methylation. We mapped the methylation patterns of the E-cadherin (E-cad) and von Hippel-Lindau (VHL) tumor suppressor gene CpG island regions in normal and neoplastic cells. Although unmethylated in normal tissue, these islands were embedded between densely methylated flanking regions containing multiple Alu repeats. These methylated flanks were segregated from the unmethylated, island CpG sites by Sp1-rich boundary regions. Finally, in human fibroblasts overexpressing DNA methyltransferase, de novo methylation of the E-cad CpG island initially involved sequences at both ends of the island and the adjacent, flanking regions and progressed with time to encompass the entire CpG island region. Together, these data suggest that boundaries exist at both ends of a CpG island to maintain the unmethylated state in normal tissue and that these boundaries may be progressively overridden, eliciting the de novo methylation associated with tumor suppressor gene silencing in neoplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268383     DOI: 10.1074/jbc.272.35.22322

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  Roles of cell division and gene transcription in the methylation of CpG islands.

Authors:  C M Bender; M L Gonzalgo; F A Gonzales; C T Nguyen; K D Robertson; P A Jones
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  SINE retroposons can be used in vivo as nucleation centers for de novo methylation.

Authors:  P Arnaud; C Goubely; T Pélissier; J M Deragon
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 3.  Epigenetic gene silencing in cancer.

Authors:  B Tycko
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation.

Authors:  Matthew C Lorincz; Dirk Schübeler; Shauna R Hutchinson; David R Dickerson; Mark Groudine
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

5.  An ectopic human XIST gene can induce chromosome inactivation in postdifferentiation human HT-1080 cells.

Authors:  Lisa L Hall; Meg Byron; Kosuke Sakai; Laura Carrel; Huntington F Willard; Jeanne B Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-18       Impact factor: 11.205

6.  Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms.

Authors:  Isabella Gazzoli; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

7.  Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation.

Authors:  Jon A Oyer; Phillip A Yates; Sarah Godsey; Mitchell S Turker
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

8.  Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.

Authors:  Kiyomi O Toyooka; Shinichi Toyooka; Anirban Maitra; Qinghua Feng; Nancy C Kiviat; Alice Smith; John D Minna; Raheela Ashfaq; Adi F Gazdar
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 9.  DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Authors:  Björn Rüter; Pierre W Wijermans; Michael Lübbert
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

10.  Predicting aberrant CpG island methylation.

Authors:  F A Feltus; E K Lee; J F Costello; C Plass; P M Vertino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.